|
2015
|
Invention
|
Compounds comprising 1,1a,2,5a-tetrahydrospiro[indole-3,2a-pyrrole]-2,5a-dione system as inhibito... |
|
|
Invention
|
Compounds comprising 1,1',2,5'-tetrahydrospiro[indole-3,2'-pyrrole]-2,5'-dione system as inhibito... |
|
2014
|
Invention
|
Duloxetine enteric coated tablet. Enteric-coated duloxetine tablet consisting of a core comprisin... |
|
|
Invention
|
Arylosulfonamides for the treatment of cns diseases. Arylsulphonamide derivatives of formula (I) ... |
|
|
Invention
|
1,5-dihydropyrrol-2-one derivatives as inhibitors of p53-mdm2/mdm4 protein-protein interaction. A... |
|
|
Invention
|
Anticancer conjugate. An anticancer conjugate, which comprises a fusion protein comprising domain... |
|
2013
|
Invention
|
A pharmaceutical composition containing candesartan cilexetil and amlodipine. A combination pharm... |
|
|
Invention
|
A pharmaceutical composition containing an ace inhibitor and a calcium channel blocker. A pharmac... |
|
|
Invention
|
Anticancer conjugate. A conjugate comprises a fusion protein comprising domain (a), which is the ... |
|
|
Invention
|
Sulphonamide derivatives of benzylamine for the treatment of cns diseases.
Sulphonamide derivati... |
|
|
Invention
|
Sulphonamide derivatives of benzylamine for the treatment of cns diseases. Sulphonamide derivativ... |
|
2012
|
Invention
|
Anticancer fusion protein. A fusion protein comprising domain (a) which is a functional fragment ... |
|
|
Invention
|
Anticancer fusion protein.
A fusion protein comprising domain (a) which is a functional fragment... |
|
|
Invention
|
Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases... |
|
|
Invention
|
Sulphonamide derivatives of alicyclic amines for the treatment of the central nervous system dise... |
|
|
Invention
|
Indoleamine derivatives for the treatment of central nervous system diseases.
Indoleamine deriva... |
|
|
Invention
|
Indoleamine derivatives for the treatment of central nervous system diseases. Indoleamine derivat... |
|
|
Invention
|
Amidoalkylpiperazinyl derivatives for the treatment of central nervous system diseases. The inven... |
|
|
Invention
|
Anticancer fusion protein.
A fusion protein comprising domain (a) which is the functional fragme... |
|
|
Invention
|
Anticancer fusion protein. A fusion protein comprising domain (a) which is the functional fragmen... |
|
2011
|
Invention
|
Anticancer htrail/pre-apoptotic effector fusion proteins. The fusion protein, especially recombin... |
|
|
Invention
|
Anticancer fusion protein. The fusion protein, especially recombinant, comprising domain (a) whic... |
|
2010
|
Invention
|
Novel chalcone derivatives with cytotoxic activity. Chalcone derivatives of the general formula (... |
|
|
Invention
|
Salts of tiotropium with 10-camphorsulfonic acid.
The present invention relates to novel tiotrop... |
|
|
Invention
|
Salts of tiotropium with 10-camphorsulfonic acid. The present invention relates to novel tiotropi... |
|
|
Invention
|
A process for the preparation of an aldehyde beta-lactam compound. The invention relates to a pro... |
|
2009
|
Invention
|
Malonic acid salt of 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- 2,4-thiazolidinedio... |
|
2007
|
Invention
|
Cristalline form of the racemic methyl-α-(2-chlorphenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin... |
|
|
Invention
|
3-phenylpropionic acid derivatives. 8 each independently represent hydrogen atom or a substituent... |
|
|
Invention
|
3-phenylpropionic acid derivatives. The invention relates to a method of treatment and/or prophyl... |
|
2006
|
Invention
|
New 3-phenylpropionic acid derivatives. The invention relates to new compounds, 3-phenylpropionic... |
|
|
Invention
|
3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands. The inven... |
|
|
Invention
|
New 3-phenylpropionic acid derivatives and their use as ppar- gamma rezeptor liganden. The invent... |
|
|
Invention
|
3-phenylpropionic acid derivatives. 8 each independently represents hydrogen atom or a substituen... |
|
|
Invention
|
3-phenylpropionic acid derivatives. 6 each independently represent hydrogen atom or a substituent... |
